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The ERCC1-XPF complex is a structure-specific endonuclease, which is involved in various DNA 
repair pathways including nucleotide excision repair and also telomere maintenance.  The 
heterodimer formation is essential for their endonuclease activity as well as the stability of each 
protein.  However, the detailed mechanism of how a cellular level of ERCC1-XPF is regulated still 
remains elusive.  In this study, to identify novel interacting factors, I conducted proteomic analysis 
after tandem purification and obtained massive numbers of candidates.  Among them, I have 
focused on DDB1- and CUL4-associated factor 7 (DCAF7, also known as WDR68/HAN11).  
Immunoprecipitation experiments suggested its dominant association with XPF but not ERCC1.  
Interestingly, siRNA-mediated knockdown of DCAF7, but not DDB1, significantly attenuated the 
cellular level of ERCC1-XPF.  The depletion of TCP1α, one of components of the molecular chaperon 
TRiC/CCT known to interact with DCAF7 and promote its folding, also reduced ERCC1-XPF level.  
Furthermore, I found that the depletion of DCAF7 causes inefficient repair of UV-induced (6-4) 
photoproducts, which can be rescued by ectopic overexpression of XPF.  Altogether, this study 
strongly suggests that DCAF7 is a novel regulator of ERCC1-XPF protein level and cellular 
nucleotide excision repair activity. 
  
Introduction 
     ERCC1-XPF is a structure-specific endonuclease involved in multiple DNA maintenance 
systems (McNeil and Melton, 2012; Manandhar et al., 2015); nucleotide excision repair (NER), 
interstrand crosslink repair, DNA double-strand break repair, and telomere maintenance.  The 
ERCC1-XPF complex makes a nick at the junction of double-stranded to single-stranded DNA 
transition with a polarity of 5’ to 3’ direction.  As a result, DNA substrates for this endonuclease 
contain a special structure such as a splayed arm, stem loop, bubble, or 3’ flap.  ERCC1 and XPF 
interact with each other via their C-terminal helix-hairpin-helix (HhH) regions.  XPF protein 
contains a catalytic domain, although the structural support of ERCC1 is required for its 
endonuclease activity.   
     The heterodimer formation of ERCC1 and XPF is also necessary for their stability (Biggerstaff 
et al., 1993; Reardon et al., 1993; van Vuuren et al., 1993).  XP-F patients carry a missense 
mutation in at least one allele of XPF/ERCC4 genes and show marginal or undetectable level of XPF 
protein, whereas ERCC1 level is also markedly reduced.  Similarly, ERCC1-mutated cells showed 
low XPF level and ERCC1 knockdown attenuated XPF protein level without affecting mRNA level.  
ERCC1 was also shown to fold only in the presence of XPF in vitro, suggesting a possible role of XPF 
as a scaffold for proper ERCC1 folding.  However, the detailed mechanism of how cellular levels of 
ERCC1 and XPF are regulated still remains elusive.  In this study, I set a goal to identify novel 
interacting factors with ERCC1-XPF, and uncover their functions to obtain new knowledge 
regarding regulatory mechanisms of ERCC1-XPF heterodimer.    
 
Materials and Methods 
For tandem affinity purification, I used Flp-In T-REx 293 cells conditionally expressing 
FLAG- and 6xHis-tagged ERCC1 or XPF upon tetracycline or doxycycline treatment.  The 
double-tagged bait proteins were isolated by Ni-NTA agarose and subsequently by anti-FLAG 
antibody resin. Bound fractions eluted with FLAG peptide were concentrated and analyzed by mass 
spectrometry. Immunoprecipitation was conducted using HEK293T cells by transfecting with 
various combinations of expression plasmids and analyzing co-immunoprecipitation of partner 
proteins with epitope-tagged bait proteins.  For RNA interference, U2OS or HeLa cells were 
transfected with various siRNAs using LipofectamineTM RNAiMAX Transfection Reagent and 
basically incubated for 72 h.  Cellular NER activity was evaluated using ELISA by measuring (6-4) 
photoproducts in genomic DNA isolated from the cells irradiated with 10 J/m2 of UV-C and incubated 
for repair. 
 
Results and Discussion 
Identification of novel interacting factors with ERCC1-XPF. 
     To explore a novel interacting protein(s) of ERCC1-XPF, I utilized Flp-In T-REx 293 cells 
conditionally expressing FLAG- and 6xHis-tagged ERCC1 or XPF.  After 48-h treatment with 
tetracycline, cell lysates were processed for tandem purification with Ni-NTA agarose and then 
anti-FLAG antibody resin.  Mass spectrometry showed 699 candidates including 14 kinds of E3 
ligases and 5 kinds of deubiquitinases.  After co-immunoprecipitation analysis and siRNA-mediated 
knockdown analysis, I identified DDB1- and CUL4-associated factor 7 (DCAF7, also known as 
WDR68/HAN11) as an interacting protein with ERCC1-XPF, which potentially regulate the cellular 
level of ERCC1-XPF.  I decided to focus on the functional analysis of DCAF7 and ERCC1-XPF 
interaction. 
 
Functional analysis of DCAF7 and ERCC1-XPF interaction.  
We first asked which subunit of the heterodimer associates with DCAF7.  I conducted 
co-immunoprecipitation analysis using XP2YO(SV) cells from XP-F patient, in which mutant XPF 
protein is undetectable and ERCC1 level is also very low due to its destabilization.  As a result, 
DCAF7 was shown to interact with XPF but not ERCC1, suggesting indirect interaction with ERCC1 
via a direct association with XPF. 
To examine a functional role of DCAF7 and ERCC1-XPF interaction, U2OS cells were 
transfected with DCAF7 siRNA.  Depletion of DCAF7 reproducibly causes significant reduction of 
ERCC1-XPF level, whereas the cellular levels of other NER factors (DDB1, DDB2 and XPB) were not 
affected.  The molecular chaperon TRiC/CCT, which plays an important role in proper folding of 
many proteins (Spiess et al., 2004; Horwich et al., 2007), has been reported to interact with DCAF7 
and promote its folding and nuclear localization (Miyata et al., 2014).  I examined the impact of 
depletion of TCP1α, one of eight subunits of TRiC/CCT, on the protein level of ERCC1-XPF.  As 
expected, TCP1α knockdown similarly reduced ERCC1-XPF level, but not DDB2 and XPA levels, 
although less efficiently compared to DCAF7 knockdown.  Taken together, these results suggest 
that DCAF7 is required for maintaining the normal cellular levels of ERCC1-XPF. 
DCAF7 is known to form a complex with Cul4-DDB1 and to function as a substrate receptor 
that determines the substrate specificity of the E3 ligase complex.  I wished to know whether the 
depletion of DDB1 also causes the downregulation of ERCC1-XPF.  However, transfection of DDB1 
siRNA affected neither the basal levels of ERCC1-XPF nor the downregulation of ERCC1-XPF upon 
DCAF7 depletion, indicating that DDB1 and probably also Cul4 are unlikely to participate in this 
mechanism.   
     ERCC1-XPF is an indispensable factor for the dual incision reaction of NER.  Given that 
DCAF7 depletion reduces the protein level of ERCC1-XPF, I wished to know the impact of DCAF7 
depletion on cellular NER activity.  DCAF7-depleted HeLa cells showed significantly slower repair 
kinetics of UV-induced (6-4) photoproducts, compared with undepleted cells.  Importantly, the 
attenuated NER activity was rescued by doxycycline-induced overexpression of exogenous XPF in 
Flp-In T-REx 293/FLAG-XPF-3xHis cells.  Collectively, these results suggest that DCAF7 plays an 
important role in maintaining normal NER activity by stabilizing XPF and hence ERCC1-XPF 
heterodimer. 
 
In this study, I demonstrated that DCAF7 is a novel interacting protein of ERCC1-XPF and 
plays an important role in maintaining the cellular level of ERCC1-XPF and hence nucleotide 
excision repair activity.  These findings provides a new insight into the regulatory mechanism of 
cellular stability of NER factors, which is crucial for sufficient NER activity.  In addition, the 
cellular level of ERCC1-XPF is well known to influence the efficacy of cisplatin-based anticancer 
chemotherapy.  The knowledge from this study may be applicable to new strategy for controlling 
ERCC1-XPF level in cancer cells. 
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 川原弘明氏から提出された学位論文について、上記 5 名の審査委員による査読後、2019
年 7月 26日に口頭発表会が行われ、同日の最終審査委員会で審議した結果、以下のとおり
判定した。	 	  










いことが示された。重要なことに、DCAF7 のノックダウンはヒト細胞の NER 活性を低下
させ、この低下は XPF の過剰発現で回復することを明らかにし、DCAF7 は ERCC1-XPF
の安定化を通して NER活性の維持に寄与していると考えられた。	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	  
	 本研究は、細胞内の ERCC1-XPF レベルと NER 活性を制御する新規調節因子として
DCAF7 を同定したものであり、細胞内の NER 調節メカニズムに新たな視点をもたらした
ものと評価され、博士（創薬科学）の学位に値すると判定した。 
 
